Lung Cancer Drugs Market Research Reports

Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • 36 Pages
From
Drug Overview: Tecentriq - Product Thumbnail Image

Drug Overview: Tecentriq

  • Drug Pipelines
  • 82 Pages
From
Drug analysis: Opdivo - Product Thumbnail Image

Drug analysis: Opdivo

  • Drug Pipelines
  • 103 Pages
From
Drug analysis: Cyramza - Product Thumbnail Image

Drug analysis: Cyramza

  • Drug Pipelines
  • 56 Pages
From
Drug Analysis: Gilotrif - Product Thumbnail Image

Drug Analysis: Gilotrif

  • Drug Pipelines
  • 31 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
Global Lung Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Lung Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • Report
From
Global Non-Small Cell Lung cancer Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Non-Small Cell Lung cancer Market Research and Forecast 2018-2023

  • Report
From
Global Lung Cancer Therapeutics Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Lung Cancer Therapeutics Market Research and Forecast, 2018-2023

  • Report
From
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 161 Pages
From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

  • Report
  • 113 Pages
From
CAS Vinblastine sulfate World Consumption Report - Product Thumbnail Image

CAS Vinblastine sulfate World Consumption Report

  • Report
  • 2001 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS 20537-88-6 Amifostine Chemical World Report - Product Thumbnail Image

CAS 20537-88-6 Amifostine Chemical World Report

  • Report
  • 2004 Pages
CAS 107868-30-4 Exemestane Chemical World Report - Product Thumbnail Image

CAS 107868-30-4 Exemestane Chemical World Report

  • Report
  • 2135 Pages
CAS 119413-54-6 Topotecan hydrochloride Chemical World Report - Product Thumbnail Image

CAS 119413-54-6 Topotecan hydrochloride Chemical World Report

  • Report
  • 2195 Pages
CAS 114915-14-9 Docetaxel intermediate Chemical World Report - Product Thumbnail Image

CAS 114915-14-9 Docetaxel intermediate Chemical World Report

  • Report
  • 2132 Pages
CAS 112901-68-5 Amifostine Chemical World Report - Product Thumbnail Image

CAS 112901-68-5 Amifostine Chemical World Report

  • Report
  • 2124 Pages
Loading Indicator

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

adroll